These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 16791582

  • 1. Effect of tofisopam on the single-oral-dose pharmacokinetics and pharmacodynamics of the cyp3a4 probe drug alprazolam.
    Drabant S, Tóth M, Bereczki A, Bajnógel J, Tömlö J, Klebovich I.
    Eur J Clin Pharmacol; 2006 Jul; 62(7):587-8. PubMed ID: 16791582
    [No Abstract] [Full Text] [Related]

  • 2. A kinetic and dynamic study of oral alprazolam with and without erythromycin in humans: in vivo evidence for the involvement of CYP3A4 in alprazolam metabolism.
    Yasui N, Otani K, Kaneko S, Ohkubo T, Osanai T, Sugawara K, Chiba K, Ishizaki T.
    Clin Pharmacol Ther; 1996 May; 59(5):514-9. PubMed ID: 8646822
    [Abstract] [Full Text] [Related]

  • 3. Effect of CYP3A5*3 genotype on the pharmacokinetics and pharmacodynamics of alprazolam in healthy subjects.
    Park JY, Kim KA, Park PW, Lee OJ, Kang DK, Shon JH, Liu KH, Shin JG.
    Clin Pharmacol Ther; 2006 Jun; 79(6):590-9. PubMed ID: 16765147
    [Abstract] [Full Text] [Related]

  • 4. Effects of repeated ingestion of grapefruit juice on the single and multiple oral-dose pharmacokinetics and pharmacodynamics of alprazolam.
    Yasui N, Kondo T, Furukori H, Kaneko S, Ohkubo T, Uno T, Osanai T, Sugawara K, Otani K.
    Psychopharmacology (Berl); 2000 Jun; 150(2):185-90. PubMed ID: 10907671
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Multiple doses of saw palmetto (Serenoa repens) did not alter cytochrome P450 2D6 and 3A4 activity in normal volunteers.
    Markowitz JS, Donovan JL, Devane CL, Taylor RM, Ruan Y, Wang JS, Chavin KD.
    Clin Pharmacol Ther; 2003 Dec; 74(6):536-42. PubMed ID: 14663456
    [Abstract] [Full Text] [Related]

  • 9. Effect of itraconazole on the single oral dose pharmacokinetics and pharmacodynamics of alprazolam.
    Yasui N, Kondo T, Otani K, Furukori H, Kaneko S, Ohkubo T, Nagasaki T, Sugawara K.
    Psychopharmacology (Berl); 1998 Oct; 139(3):269-73. PubMed ID: 9784084
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Kinetics and dynamics of intravenous adinazolam, N-desmethyl adinazolam, and alprazolam in healthy volunteers.
    Venkatakrishnan K, Culm KE, Ehrenberg BL, Harmatz JS, Corbett KE, Fleishaker JC, Greenblatt DJ.
    J Clin Pharmacol; 2005 May; 45(5):529-37. PubMed ID: 15831776
    [Abstract] [Full Text] [Related]

  • 13. Tofisopam inhibits the pharmacokinetics of CYP3A4 substrate midazolam.
    Tóth M, Drabant S, Varga B, Végso G, Cseh A, Szentpéteri I, Klebovich I.
    Eur J Clin Pharmacol; 2008 Jan; 64(1):93-4. PubMed ID: 17989974
    [No Abstract] [Full Text] [Related]

  • 14. Dose-response evaluation of the interaction between sertraline and alprazolam in vivo.
    Hassan PC, Sproule BA, Naranjo CA, Herrmann N.
    J Clin Psychopharmacol; 2000 Apr; 20(2):150-8. PubMed ID: 10770452
    [Abstract] [Full Text] [Related]

  • 15. [Effect of tofisopam on CYP3A4 enzyme activity on human recombinant 3A4 supersome].
    Tóth M, Bajnógel J, Egyed A, Drabant S, Tömlo J, Klebovich I.
    Acta Pharm Hung; 2005 Apr; 75(4):195-8. PubMed ID: 16711396
    [Abstract] [Full Text] [Related]

  • 16. Cytochrome p450 3A4 messenger ribonucleic acid induction by rifampin in human peripheral blood mononuclear cells: correlation with alprazolam pharmacokinetics.
    Gashaw I, Kirchheiner J, Goldammer M, Bauer S, Seidemann J, Zoller K, Mrozikiewicz PM, Roots I, Brockmöller J.
    Clin Pharmacol Ther; 2003 Nov; 74(5):448-57. PubMed ID: 14586385
    [Abstract] [Full Text] [Related]

  • 17. Coadministration of nefazodone and benzodiazepines: III. A pharmacokinetic interaction study with alprazolam.
    Greene DS, Salazar DE, Dockens RC, Kroboth P, Barbhaiya RH.
    J Clin Psychopharmacol; 1995 Dec; 15(6):399-408. PubMed ID: 8748428
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetic and pharmacodynamic evaluation of the inhibition of alprazolam by citalopram and fluoxetine.
    Hall J, Naranjo CA, Sproule BA, Herrmann N.
    J Clin Psychopharmacol; 2003 Aug; 23(4):349-57. PubMed ID: 12920410
    [Abstract] [Full Text] [Related]

  • 19. Alprazolam-ritonavir interaction: implications for product labeling.
    Greenblatt DJ, von Moltke LL, Harmatz JS, Durol AL, Daily JP, Graf JA, Mertzanis P, Hoffman JL, Shader RI.
    Clin Pharmacol Ther; 2000 Apr; 67(4):335-41. PubMed ID: 10801241
    [Abstract] [Full Text] [Related]

  • 20. Selegiline transdermal system: an examination of the potential for CYP450-dependent pharmacokinetic interactions with 3 psychotropic medications.
    Azzaro AJ, Ziemniak J, Kemper E, Campbell BJ, VanDenBerg C.
    J Clin Pharmacol; 2007 Feb; 47(2):146-58. PubMed ID: 17244765
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.